Search results for: England
Filter search results
GLP-1 Receptor Agonists: Shifting Obesity Management
12 May 2025
…both public and private health systems. Societal preference research can help achieve this. For example, a recent OHE study explored views in England and Wales on prioritising new medical treatments….
OHE submission to the UK Parliamentary Inquiry on an Ageing Society
20 May 2025
…fertility rate (TFR) in England and Wales dropped to its lowest value on record (1.44 children per woman). Advances in quality of life – with more women participating in the workforce,…
Pharmacogenomics Testing: A Crucial Piece to Unlocking the Full Value of Medicines
5 June 2025
Join us for an online CERSI-PGx Health Economics Workshop on 10 June 2025, from 13:00–17:00 BST, with experts from NHS England, NICE, the University of Manchester, and Bangor University….
From STEDI to STRIDES: Valuing broader health-system benefits of AMR diagnostics
21 July 2025
…antimicrobials – Spectrum, Transmission, Enablement, Diversity, and Insurance value. The STEDI-framework ultimately formed the basis of the NICE-NHS England subscription model for evaluating and purchasing antimicrobials in the UK. The…
OHE’s submission to a parliamentary inquiry on UK drug shortages
6 October 2025
…of some recent drug shortages. For example, in England, the surge in respiratory infections, particularly strep A, has led to Amoxicillin shortages. Increased demand, sudden changes in prescribing, and growing prevalence…
New OHE model estimates COVID-19 could be associated with costs of £7 billion a year in the UK, without annual autumn vaccinations
13 October 2025
…Vaccination and Immunisation (JCVI) recommended that the age-based eligibility criteria for England’s 2025 autumn vaccination schedule be brought up to ages 75+, from 65+ in the previous years. OHE’s…
Turning around the NHS: Reflections on the 2025 OHE Annual Lecture
14 October 2025
…people living with major illness in the next decade. Figure 4: Average years of life people spend in different states of ill health, England, 2010, 2019 and projected for 2040…
Europe’s pharmaceutical policy choices – And what the United States stands to learn
18 March 2026
…misleading. For example, NICE in England approves just over four out of five medicines it appraises. But many approvals are conditional or restricted to smaller patient populations. Some medicines never enter…
OHE responds to the NHS Ten Year Plan
3 July 2025
Professor Graham Cookson responds to the Ten Year Health Plan for England….